Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus–Angelica Combination

<div>Expression of Col-I and FN in the intima of proliferative vessels. (a) Immunohistochemical results of Col-I (× 400, Bar = 50μm). (b) Immunohistochemical results of FN (× 400, Bar = 50μm). (c) Comparison of Col-I and FN expression among the groups ( ± s, n = 8) 1. Normal. 2. Model group. 3. Astragalus. 4. Angelica. 5. Astragalus–Angelica 1:1. 6. Astragalus–Angelica 5:1. 7. Atorvastatin. ※P &lt; 0.05, ※※P &lt; 0.01 versus normal group; ■P &lt; 0.05, ■■P &lt; 0.01 versus model group; □P &lt; 0.05, □□P &lt; 0.01 versus Atorvastatin group.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus–Angelica Combination 

Figure 5 | Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus–Angelica Combination 